Cancer stem cells that survive after a tumor is treated go on to form new tumors that do not respond to further treatment.

Trevor Reese is 26 years old and is battling Glioblastoma brain cancer. Reese and his family learned about ... The treatment ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

As a surgical strategy for the management of glioblastoma, lobectomy improves overall survival and PFS by approximately 1 year, demonstrating its promise.

These targets were identified through a screen for genetic vulnerabilities in patient-derived cancer stem cells that ...

Walkers and runners laced up their shoes in Richmond on Sunday, with every stride getting them one step closer to helping ...

Glioblastoma, a highly aggressive brain cancer, poses survival challenges with current treatments like surgery and chemotherapy. Immunotherapy offers hope by leveraging the immune system against ...

Charlie, like so many others, had so much life left to live but sadly that was not to be. The memory of him, symbolised by ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.